The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Maintenance immunosuppressive therapy with resumption of immune checkpoint inhibitor treatment to reduce recurrence of immune-mediated colitis.
 
Hamzah Abu-Sbeih
No Relationships to Disclose
 
Fangwen Zou
No Relationships to Disclose
 
Barbara Dutra
No Relationships to Disclose
 
Mehmet Altan
Consulting or Advisory Role - GlaxoSmithKline; Shattuck Labs
Research Funding - Adaptimmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Shattuck Labs (Inst)
 
Jennifer Leigh McQuade
Honoraria - Merck
Consulting or Advisory Role - Bristol Myer Squibb; Roche Pharma AG
Travel, Accommodations, Expenses - Merck
 
John A. Thompson
Consulting or Advisory Role - Academy for Continued Healthcare Learning; Alpine Immune Sciences; BJ Bioscience; Calithera Biosciences; Clinical Care Options/NCCN; Meeting Sites Pro; Neoleukin Therapeutics; Seagen
Research Funding - Admune Therapeutics (Inst); Agensys (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Trillium Therapeutics (Inst); Xencor (Inst)
 
Anusha Thomas
No Relationships to Disclose
 
Yinghong Wang
Consulting or Advisory Role - Tillotts Pharma